Infraestructura de Medicina de Precisión asociada a la Ciencia y la Tecnología
IMPaCT MEETING
18 Nov 2024 – form 09:30 to 18:00

precision medicine projects

Results for: Diagnosis

PMP24/00025
2024
CASTILLA Y LEÓN
Dr. María Díez Campelo
,
UMBRELLA-SUMMA LEGACY
More info.
PMPER24/00007
2026
ANDALUSIA, CANARY ISLANDS, CANTABRIA, CASTILLA LA MANCHA, CATALONIA, COMMUNITY OF VALENCIA, MADRID, BASQUE COUNTRY
Gisela Nogales Gadea and Arturo López Castel
Creation of an integral node for Myotonic Dystrophy type 1 in Spain: clinical registry, genomic, epigenomic and proteomic maps (DM1-Hub)
More info.
PMP22/00185
2022
GALICIA
Moisés Rodríguez Mañero
Integration of polygenic risk scores with multiparametric information in patient-specific prediction of the onset, progression, and therapeutic response to atrial fibrillation
More info.
PMP24/00008
2025
MADRID
Esther García García-Esquinas / Maria José Sánchez
AMBISiON-IMPaCT: Enrichment of the IMPaCT cohort with ENVIRONMENTAL and Eye Health measures for preventive precision medicine
More info.
PMP22/00030
2025
ANDALUSIA, CANTABRIA, CASTILLA LA MANCHA, CATALONIA, COMMUNITY OF VALENCIA, EXTREMADURA, BALEARIC ISLANDS, LA RIOJA, MADRID, BASQUE COUNTRY
Dr. Ferran Barbé Illa
Impact of Sleep Respiratory Disorder Management on the Control of Systemic Hypertension: METASLEEP Project
More info.
PMP21/00057
2021
MADRID
Guadalupe Sabio
Therapeutic Targets and Biomarkers for Precision Medicine in MAFLD (PreMed-MAFLD)
More info.
PMP22/00008
2022
CATALONIA
Rafael Artuch
UNIQUE. Implementation of a Pediatric Network for Personalised Medicine in rare pediatric diseases. A Pilot Project.
More info.
PMP22/00064
2022
CATALONIA
Dr. Conxi Lázaro
IMPaCT_VUSCan: Development and application of a functional genomics platform for unsolved hereditary cancer cases
More info.
PMP22/00088
2022
ANDALUSIA, ASTURIAS, CANTABRIA, CATALONIA, COMMUNITY OF VALENCIA, BALEARIC ISLANDS, MADRID, BASQUE COUNTRY
Elisabet Vilella Square
Pilot study of implementation of a screening tool for the prevention, diagnosis and treatment of patients with a psychiatric neurodevelopmental disorder: use of the 22q11.2 deletion syndrome (22q11.2DS) as a model.
More info.
PMP22/00092
2022
ANDALUSIA, ARAGON, BALEARIC, CANARY ISLANDS, CASTILLA Y LEÓN, CATALONIA, GALICIA, MADRID
Jesús Oteo Iglesias
Precision Medicine against Antimicrobial Resistance. (MePRAM)
More info.
1 / 21
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.